The last three decades have seen the emergence of a cornucopia of antimicrobials in the cephalosporin class. This becomes even more apparent when one realizes that over 60 pages of the 1993 AHFS drug information text is dedicated to the cephalosporin class.1 Due to similarities in nomenclature and the proliferation of available agents, the clinician is constantly challenged by this confusing array of antimicrobials. The intent of this manuscript will be to distill the volumes of information available on cephalosporins into a more manageable format and close with a summary of the most clinically important cephalosporin antimicrobials.
Get full access to this article
View all access options for this article.
References
1.
American Hospital Formulary Service Drug Information.McEvoyG.K. (ed), 1993; 92–159, American Society of Hospital Pharmacists, Bethesda, MD.
2.
Cephalosporins and Related Agents, AMA Drug Evaluations; 1992; 1275–1332.
3.
SaxonA., BeallG.N., RhorA.S., AdelmanD.C.Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Internal Med1987; 107: 204–215.
4.
VanArsdelPPJr., MillerS.Antimicrobial treatment of patients with a penicillin allergy history. J Allergy Clin Immunol1990; 85: 188.
5.
SattlerF.R., WeitekampM.R., BallardJ.O.Potential for bleeding with the new beta-lactam antibiotics. Ann Intern Med1986; 105: 24–931.
6.
Drugs for anaerobic infection. Med Lett Drugs Ther1984; 26: 87–89.
7.
TalleyF.P.: Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother1983; 23: 536.
8.
MarksW.A.: Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: Multicenter randomized controlled trial. J Pediatr1986; 109: 123–130.
9.
SchaadU.B.: Comparison of ceftriaxone and cefuroxime for treatment of bacterial meningitis in children. N Engl J Med1988; 148: 343–348.
10.
Loracarbef.Med Lett Drugs Ther1992; 34: 87–88.
11.
FinkS.Ceftriaxone effect on bilirubin-albumin binding. Pediatrics1987; 80: 873–875.
12.
SchaadU.B.: Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet1988; 2: 1411–1413.
13.
PigrauC.: Ceftriaxone associated biliary pseudolithiasis in adults. Lancet1989; 2: 165.
14.
Treatment of Lyme disease.Med Lett Drugs Ther1989; 31: 57–59.
15.
TaylorD.N.: Comparative study of ceftriaxone and tirmethoprin/sulamethoxazole for treatment of chanchroid in Thailand. J Infect Dis1985; 152: 1002–1006.
Ceftriaxone sodium. Med Lett Drugs Ther1985; 27: 37–39.
18.
DattwylerR.J.Treatment of late Lyme borreliosis: Randomized comparison of ceftriaxone and penicillin. Lancet1988; 1: 1191–1194.
19.
American Academy of Pediatrics Committee on Infectious Diseases: Treatment of bacterial meningitis. Pediatrics1988; 81: 904–907.
20.
WeitekampM.R., and AberR.C.Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA1983; 249: 69–71.
21.
WeitekampM.R.Effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers. J Antimicrob Chemother1985; 16: 95–101.
22.
JonesR.N., and ThornsberryC.Gram-positive superinfections: Consequence of modern b-lactam chemotherapy. Antimicrob Newslett1985; 2: 17–24.
23.
TallyF.P.Safety profile of cefixime. Pediatr Infect Dis J1987; 6: 976–980.
24.
McLinnSERandomize, open label multicenter trial of cefixime compared with amoxicillin for treatment of acute otitis media with effusion. Pediatr Infect Dis J1987; 6: 997–1001.
25.
HowieV.M., and OwenM.J.Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media. Pediatr Infect Dis J1987; 6: 989–991.
